US Patent Issued to University of South Florida on June 30 for "Recombinant fusion protein vaccine containing Clostridioides difficile FliC and FliD" (Florida Inventor)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,609, issued on June 30, was assigned to University of South Florida (Tampa, Fla.).

"Recombinant fusion protein vaccine containing Clostridioides difficile FliC and FliD" was invented by Xingmin Sun (Temple Terrace, Fla.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A novel vaccine and methods of preventing and treating C. difficile infection in a patient is described. The vaccine is comprised of a fusion protein (denoted FliCD) comprised of the FliC and FliD from C. difficile and joined by a linker sequence. Administration of the vaccine, as well as anti-FliCD serum, has been shown to prevent C. difficile infection as well as treat existing infecti...